ZNF768
gene geneOn this page
Also known as FLJ23436
Summary
ZNF768 (zinc finger protein 768, HGNC:26273) is a protein-coding gene on chromosome 16p11.2, encoding Zinc finger protein 768 (Q9H5H4). Binds to mammalian-wide interspersed repeat (MIRs) sequences in euchromatin and promoter regions of genes at the consensus sequence 5’-GCTGTGTG-[N20]-CCTCTCTG-3’, consisting of two anchor regions connected by a linker region; the linker region probably does not contribute to the….
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromosome. Predicted to be active in nucleus.
Source: NCBI Gene 79724 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_024671
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26273 |
| Approved symbol | ZNF768 |
| Name | zinc finger protein 768 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23436 |
| Ensembl gene | ENSG00000169957 |
| Ensembl biotype | protein_coding |
| OMIM | 618032 |
| Entrez | 79724 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000380412, ENST00000562803
RefSeq mRNA: 1 — MANE Select: NM_024671
NM_024671
CCDS: CCDS10681
Canonical transcript exons
ENST00000380412 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000871524 | 30524004 | 30526051 |
| ENSE00001028718 | 30526326 | 30526566 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 96.71.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0011 / max 110.0044, expressed in 1708 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157057 | 5.9767 | 1662 |
| 157058 | 2.0244 | 1166 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 96.71 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.55 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.30 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 94.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.16 | gold quality |
| muscle of leg | UBERON:0001383 | 93.50 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 93.24 | gold quality |
| body of tongue | UBERON:0011876 | 92.63 | gold quality |
| ventricular zone | UBERON:0003053 | 92.39 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.17 | gold quality |
| muscle organ | UBERON:0001630 | 92.04 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.98 | gold quality |
| vena cava | UBERON:0004087 | 91.97 | silver quality |
| transverse colon | UBERON:0001157 | 91.96 | gold quality |
| lower esophagus | UBERON:0013473 | 91.95 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 91.95 | gold quality |
| cardiac ventricle | UBERON:0002082 | 91.92 | gold quality |
| nipple | UBERON:0002030 | 91.59 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.08 | gold quality |
| fundus of stomach | UBERON:0001160 | 91.04 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 90.94 | gold quality |
| tongue | UBERON:0001723 | 90.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.83 | gold quality |
| pylorus | UBERON:0001166 | 90.75 | gold quality |
| right testis | UBERON:0004534 | 90.70 | gold quality |
| left testis | UBERON:0004533 | 90.60 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.55 | gold quality |
| cardiac atrium | UBERON:0002081 | 90.50 | gold quality |
| heart | UBERON:0000948 | 90.44 | gold quality |
| renal medulla | UBERON:0000362 | 90.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.36 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1731.1 | ZNF768 | More than 3 adjacent zinc fingers |
| MA1731.2 | ZNF768 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:30476274
miRNA regulators (miRDB)
12 targeting ZNF768, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-7158-3P | 98.46 | 66.45 | 728 |
| HSA-MIR-203B-3P | 97.82 | 66.27 | 979 |
| HSA-MIR-4680-5P | 96.43 | 67.15 | 893 |
Literature-anchored findings (GeneRIF, showing 2)
- High ZNF768 expression is associated with colorectal cancer. (PMID:25875936)
- A report on the specific binding of zinc finger protein ZNF768 to the sequence motif GCTGTGTG (N20) CCTCTCTG in the core region of mammalian-wide interspersed repeats. (PMID:30476274)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp768 | ENSMUSG00000047371 |
| rattus_norvegicus | Zfp768 | ENSRNOG00000029490 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 768 — Q9H5H4 (reviewed: Q9H5H4)
All UniProt accessions (2): Q9H5H4, H3BS42
UniProt curated annotations — full annotation on UniProt →
Function. Binds to mammalian-wide interspersed repeat (MIRs) sequences in euchromatin and promoter regions of genes at the consensus sequence 5’-GCTGTGTG-[N20]-CCTCTCTG-3’, consisting of two anchor regions connected by a linker region; the linker region probably does not contribute to the binding specificity. Required for cell homeostasis. May be involved in transcriptional regulation.
Subunit / interactions. Interacts (via zinc-finger domains) with TP53 (via N-terminus); interaction might be facilitated by TP53 oligomerization state. Interacts with ELP3.
Subcellular location. Nucleus. Chromosome.
Post-translational modifications. May be phosphorylated at residue ‘Ser-5’ of the tandem heptapeptide repeats in the N-terminus. Phosphorylation might be increased upon RAS pathway activation and negatively regulate protein stability.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_078947* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000684 | RNA_pol_II_repeat_euk | Repeat |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF05001
UniProt features (60 total): modified residue 31, zinc finger region 10, mutagenesis site 10, compositionally biased region 4, region of interest 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H5H4-F1 | 64.46 | 0.17 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (31): 17, 18, 23, 27, 33, 62, 69, 76, 83, 90, 97, 104, 107, 111, 118, 125, 128, 132, 135, 139 …
Mutagenesis-validated functional residues (10):
| Position | Phenotype |
|---|---|
| 62 | increases protein stability. |
| 69 | increases protein stability. |
| 76 | increases protein stability. |
| 83 | increases protein stability. |
| 90 | no effect on protein stability. |
| 97 | no effect on protein stability. |
| 125 | no effect on protein stability. |
| 132 | no effect on protein stability. |
| 139 | increases protein stability. |
| 160 | no effect on protein stability. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 97 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, TGACCTY_ERR1_Q2, SP1_Q2_01, NF1_Q6_01, chr16p11, AACTTT_UNKNOWN, RYTTCCTG_ETS2_B, P300_01, WHN_B, RFX1_02, TGTYNNNNNRGCARM_UNKNOWN, NERF_Q2, CETS1P54_01
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), transcription by RNA polymerase II (GO:0006366)
GO Molecular Function (8): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), RNA binding (GO:0003723), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
898 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF768 | ZNF511 | Q8NB15 | 485 |
| ZNF768 | DNMBP | Q6XZF7 | 473 |
| ZNF768 | ZNF638 | Q14966 | 447 |
| ZNF768 | C6orf163 | Q5TEZ5 | 434 |
| ZNF768 | USP36 | Q9P275 | 429 |
| ZNF768 | CFAP107 | Q8N1D5 | 418 |
| ZNF768 | KAT8 | Q9H7Z6 | 418 |
| ZNF768 | ZNF853 | P0CG23 | 405 |
| ZNF768 | ITGAL | P20701 | 404 |
| ZNF768 | RAPGEF1 | Q13905 | 400 |
| ZNF768 | ZNF346 | Q9UL40 | 393 |
| ZNF768 | ZNF521 | Q96K83 | 389 |
| ZNF768 | ZNF148 | Q9UQR1 | 384 |
| ZNF768 | ZNF232 | Q9UNY5 | 378 |
| ZNF768 | WHAMM | Q8TF30 | 377 |
IntAct
158 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RPL14 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| GABARAP | IPO5 | psi-mi:“MI:0914”(association) | 0.590 |
| PIN1 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP2 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF768 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF250 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLK2 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF648 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF417 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF768 | ZNF835 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMG1 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM34 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| N | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| NIFK | RSL1D1 | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| SULF2 | UBTF | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF768 | RPS10 | psi-mi:“MI:0915”(physical association) | 0.500 |
| ZNF277 | ZNF768 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (141): ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Proximity Label-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS), ZNF768 (Affinity Capture-MS)
ESM2 similar proteins: A0A0J9YY54, A4FU49, A5D7L8, E9Q6E9, F1LWT0, O14686, O15069, P21263, P79386, Q149B8, Q28256, Q2EG98, Q4JF29, Q4R729, Q5HY64, Q5JRC9, Q6P5H2, Q6PDK2, Q70KF4, Q80UE6, Q8CHD8, Q8K327, Q8N1P7, Q8N5Q1, Q8N693, Q8N7U7, Q8NA70, Q8R0T2, Q96DU7, Q96J92, Q96JM3, Q96QH2, Q99KW3, Q99PG2, Q9BE18, Q9BG94, Q9CWU5, Q9DGW5, Q9H5H4, Q9H7P9
Diamond homologs: A1YEV9, A1YG26, A1YG60, A2ANX9, A2T712, A2T736, A2T7L7, A3KN32, A7Y7X5, B0K011, E9Q6W4, O14771, O15391, O35738, O43474, O62836, O95125, P08048, P0CG23, P10925, P17010, P17012, P17022, P17041, P20662, P24399, P25490, P28698, P51815, P52736, P57682, P80944, P86413, P98182, Q00899, Q01611, Q07231, Q08DS3, Q14929, Q15776
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 138 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Peptide chain elongation | 18 | 25.9× | 7e-19 |
| Viral mRNA Translation | 18 | 25.9× | 7e-19 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 18 | 25.7× | 7e-19 |
| Selenocysteine synthesis | 18 | 24.6× | 1e-18 |
| Eukaryotic Translation Termination | 18 | 24.6× | 1e-18 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 18 | 24.1× | 1e-18 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 18 | 24.1× | 1e-18 |
| Formation of a pool of free 40S subunits | 18 | 22.9× | 2e-18 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 19 | 27.9× | 8e-20 |
| translation | 19 | 15.5× | 5e-15 |
| RNA processing | 7 | 12.2× | 3e-04 |
| rRNA processing | 10 | 11.2× | 5e-06 |
| ribosomal small subunit biogenesis | 6 | 10.8× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
262 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:30526325:CCT:C | donor_gain | 1.0000 |
| 16:30526052:C:CC | acceptor_gain | 0.9900 |
| 16:30526052:CTGCA:C | acceptor_loss | 0.9900 |
| 16:30526261:C:A | donor_gain | 0.9900 |
| 16:30526316:C:CA | donor_gain | 0.9900 |
| 16:30526322:TCACC:T | donor_loss | 0.9900 |
| 16:30526325:C:CT | donor_loss | 0.9900 |
| 16:30526373:T:TA | donor_gain | 0.9900 |
| 16:30526053:T:C | acceptor_loss | 0.9800 |
| 16:30526048:TTGC:T | acceptor_gain | 0.9700 |
| 16:30526056:A:T | acceptor_gain | 0.9700 |
| 16:30526319:T:TA | donor_gain | 0.9700 |
| 16:30526329:TGAGG:T | donor_gain | 0.9700 |
| 16:30526049:TGC:T | acceptor_gain | 0.9600 |
| 16:30526055:C:CT | acceptor_gain | 0.9600 |
| 16:30526059:A:AC | acceptor_gain | 0.9600 |
| 16:30526257:C:CA | donor_gain | 0.9600 |
| 16:30526324:A:AC | donor_gain | 0.9600 |
| 16:30526325:C:CC | donor_gain | 0.9600 |
| 16:30526050:GC:G | acceptor_gain | 0.9500 |
| 16:30526051:CC:C | acceptor_gain | 0.9500 |
| 16:30526273:AGCC:A | donor_gain | 0.9500 |
| 16:30526047:GTTGC:G | acceptor_gain | 0.9400 |
| 16:30526332:G:C | donor_gain | 0.9300 |
| 16:30526282:T:TA | donor_gain | 0.9200 |
| 16:30526059:A:C | acceptor_gain | 0.9100 |
| 16:30526323:CACC:C | donor_loss | 0.8900 |
| 16:30526276:C:A | donor_gain | 0.8700 |
| 16:30526653:A:AC | donor_gain | 0.8600 |
| 16:30526654:C:CC | donor_gain | 0.8600 |
AlphaMissense
3568 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:30524557:A:G | L528P | 1.000 |
| 16:30524574:G:C | F522L | 1.000 |
| 16:30524574:G:T | F522L | 1.000 |
| 16:30524576:A:G | F522L | 1.000 |
| 16:30524658:G:C | F494L | 1.000 |
| 16:30524658:G:T | F494L | 1.000 |
| 16:30524660:A:G | F494L | 1.000 |
| 16:30524742:G:C | F466L | 1.000 |
| 16:30524742:G:T | F466L | 1.000 |
| 16:30524744:A:G | F466L | 1.000 |
| 16:30525078:G:C | F354L | 1.000 |
| 16:30525078:G:T | F354L | 1.000 |
| 16:30525080:A:G | F354L | 1.000 |
| 16:30525145:A:G | L332P | 1.000 |
| 16:30525162:G:C | F326L | 1.000 |
| 16:30525162:G:T | F326L | 1.000 |
| 16:30525164:A:G | F326L | 1.000 |
| 16:30525207:G:C | H311Q | 1.000 |
| 16:30525207:G:T | H311Q | 1.000 |
| 16:30525214:C:G | R309P | 1.000 |
| 16:30525219:G:C | H307Q | 1.000 |
| 16:30525219:G:T | H307Q | 1.000 |
| 16:30525221:G:C | H307D | 1.000 |
| 16:30525229:A:G | L304P | 1.000 |
| 16:30525246:G:C | F298L | 1.000 |
| 16:30525246:G:T | F298L | 1.000 |
| 16:30525247:A:G | F298S | 1.000 |
| 16:30525248:A:G | F298L | 1.000 |
| 16:30525248:A:T | F298I | 1.000 |
| 16:30525291:G:C | H283Q | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000200368 (16:30525419 C>A,T), RS1000220204 (16:30527561 C>A,G), RS1000720862 (16:30527392 G>C), RS1000868120 (16:30530020 G>A,T), RS1000978717 (16:30530482 G>A), RS1001435015 (16:30526140 T>C), RS1002057521 (16:30527931 T>G), RS1002197056 (16:30530932 C>T), RS1002284318 (16:30533754 A>G), RS1002328110 (16:30524123 C>T), RS1002439579 (16:30524381 A>C), RS1002663155 (16:30523514 A>G), RS1002718125 (16:30531243 C>T), RS1002879706 (16:30527321 C>G,T), RS1002994276 (16:30527491 T>C)
Disease associations
OMIM: gene MIM:618032 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation, affects cotreatment, increases expression, decreases expression | 3 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| geraniol | increases expression | 1 |
| lead acetate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| coumarin | increases phosphorylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| Bortezomib | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Hydralazine | increases expression, affects cotreatment | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Selenium | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Vitamin E | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW81 | HEK293 eGFP-ZNF768 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.